Home / NEWS / Top News / Stocks making the biggest moves after the bell: Cal-Maine Foods, Myriad Genetics & more

Stocks making the biggest moves after the bell: Cal-Maine Foods, Myriad Genetics & more

Cases of eggs from Cal-Maine Foods, Inc., await to be transfer manacled out by the Mississippi Department of Agriculture and Commerce employees to several hundred families along with over 1,400 hits of meat products from Merchants Foodservice and 2,200 gallons of milk from Borden Dairy, at the Mississippi Situation Fairgrounds in Jackson, Miss., Aug. 7, 2020.

Rogelio V. Solis | AP

Check out the companies making headlines after the bell on Tuesday:

Cal-Maine Foods — Cal-Maine Foods announced a surprise profit for its fiscal second quarter, sending the stock up more than 2% after-hours trading. The attendance posted earnings per share of 25 cents on revenue of $347.3 million. Analysts polled by FactSet expected a set-back of 8 cents pre share on revenue of $333.5 million. The company’s egg-dozen sales grew by 4.6% on a year-over-year basis.

Myriad Genetics — Allocates of the biotechnology company rose nearly 2% on news Myriad will explore “strategic alternatives” for its autoimmune province. The company is also restructuring its international operations.

Smart Global Holdings — Smart Global posted fiscal first-quarter earnings per equity that were better than expected, lifting the computer-memory manufacturer’s stock up by 2.4%. Smart Global reported arbitrated earnings per share of 78 cents, topping a FactSet estimate of 70 cents per share. The company also issued better-than-expected net income guidance for the current quarter.

Nektar Therapeutics — Nektar shares slipped about 1% after the company divulged Dr. Brian Kotzin will take over as interim chief medical officer, effective immediately, replacing stylish CMO Wei Lin.

Check Also

Pfizer says its Covid vaccine trial for kids ages 12 to 15 is fully enrolled

Walgreens Pharmacologist Jessica Sahni holds the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at The New Jewish …

Leave a Reply

Your email address will not be published. Required fields are marked *